We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Karyopharm Therapeutics
KPTI
$48M
| $6.92M | ﹤0.01% |
118,569
+12,322
| +12% | +$608K |
|
1677
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.6M
| $6.91M | ﹤0.01% |
300,000
| – | – |
|
1678
Cracker Barrel
CBRL
$1.29B
| $6.91M | ﹤0.01% |
60,815
-3,307
| -5% | -$361K |
|
1679
Methode Electronics
MEI
$592M
| $6.89M | ﹤0.01% |
157,030
-12,196
| -7% | -$565K |
|
1680
Codexis
CDXS
$158M
| $6.89M | ﹤0.01% |
1,664,302
+83,214
| +5% | +$436K |
|
1681
Alamo Group
ALG
$2.05B
| $6.89M | ﹤0.01% |
37,405
+8,836
| +31% | +$1.45M |
|
1682
Winnebago Industries
WGO
$909M
| $6.86M | ﹤0.01% |
118,851
-9,015
| -7% | -$550K |
|
|
ECHO
1683
EchoStar
ECHO
$26.2B
| $6.86M | ﹤0.01% |
374,804
-57,473
| -13% | -$1.05M |
|
1684
Nuveen ESG Large-Cap ETF
NULC
$72.8M
| $6.84M | ﹤0.01% |
200,000
| – | – |
|
1685
Recursion Pharmaceuticals
RXRX
$1.73B
| $6.84M | ﹤0.01% |
1,025,585
-121,844
| -11% | -$967K |
|
|
UMH
1686
UMH Properties
UMH
$1.36B
| $6.84M | ﹤0.01% |
462,448
+267,145
| +137% | +$4.39M |
|
1687
Archrock
AROC
$5.8B
| $6.84M | ﹤0.01% |
699,910
-25,450
| -4% | -$249K |
|
1688
PAR Technology
PAR
$735M
| $6.83M | ﹤0.01% |
201,128
-6,452
| -3% | -$215K |
|
1689
Highwoods Properties
HIW
$3.47B
| $6.82M | ﹤0.01% |
293,896
-148,532
| -34% | -$4M |
|
1690
Glaukos
GKOS
$10.6B
| $6.81M | ﹤0.01% |
135,959
-19,833
| -13% | -$963K |
|
1691
Evolus
EOLS
$501M
| $6.8M | ﹤0.01% |
803,458
-125,933
| -14% | -$1.14M |
|
1692
AZZ Inc
AZZ
$4.54B
| $6.79M | ﹤0.01% |
164,763
-54,585
| -25% | -$2.24M |
|
|
GTY
1693
Getty Realty Corp
GTY
$2.07B
| $6.79M | ﹤0.01% |
188,607
+56,661
| +43% | +$1.98M |
|
|
NEX
1694
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $6.79M | ﹤0.01% |
854,636
-827,327
| -49% | -$7.4M |
|
1695
CorVel
CRVL
$3.19B
| $6.76M | ﹤0.01% |
106,524
-2,472
| -2% | -$144K |
|
1696
Franklin Covey
FC
$246M
| $6.74M | ﹤0.01% |
175,202
-6,585
| -4% | -$304K |
|
1697
PJT Partners
PJT
$4.38B
| $6.72M | ﹤0.01% |
93,113
+279
| +0.3% | +$21.4K |
|
|
AGR
1698
DELISTED
Avangrid, Inc.
AGR
| $6.72M | ﹤0.01% |
168,495
+505
| +0.3% | +$20.6K |
|
1699
Alpha Metallurgical Resources
AMR
$1.93B
| $6.7M | ﹤0.01% |
42,933
-4,004
| -9% | -$641K |
|
|
DAWN
1700
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.67M | ﹤0.01% |
498,791
+77,664
| +18% | +$1.52M |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.